Viking Therapeutics stock holds Buy rating at Laidlaw despite safety concerns – RP Digital

Business

Viking Therapeutics stock holds Buy rating at Laidlaw despite safety concerns

August 20, 20251 min0

Viking Therapeutics stock holds Buy rating at Laidlaw despite safety concerns

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

BancFirst declares quarterly dividend and trust interest payment

rpdigitalAugust 28, 20250

Jefferies raises Ollie's Bargain Outlet stock price target to $135 on strong growth

rpdigitalAugust 28, 20250